Universal Ibogaine advises further on application for Management Cease Trade Order

Calgary, AB – December 2, 2025 – TheNewswire – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with a mission to research and deliver medicalized ibogaine-centered addiction care, advises of the following additional points related to its prior News Release of November 25, 2025 regarding its application to the Alberta Securities Commission (the “ Continue Reading →

Page 23 of 123 «...10202122232425...»
UA-77446339-1